9:31 ET - Pharmaceutical makers better beware rejecting a deal. Starboard has its next big board change with a settlement today giving it five of 11 directors, eventually, at Perrigo (PRGO). It's Starboard's biggest bet right now with a 6.7% stake and CEO Jeff Smith is taking a seat, a sign the activist fund is particularly focused on PRGO. PRGO shareholders 15 months ago batted away a $26B bid, but shares have slumped since, essentially opening the door for Starboard. In October, Starboard settled for 3 of 9 seats at DepoMed (DEPO), which it also criticized for rejecting an approach. Macy's (M) may want to remember this too if it balks too quickly at approach from Hudson's Bay (HBC.T) that WSJ reported last week. PRGO gains 1.6% to $79.33 (david.benoit@wsj.com; @DaveCBenoit)

(END) Dow Jones Newswires

February 07, 2017 09:46 ET (14:46 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.
Macys (NYSE:M)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Macys Charts.
Macys (NYSE:M)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Macys Charts.